WEBINAR Early Clinical Trials: the good, the bad, and the ugly

In this webinar from 3D-PharmXchange you will learn about:

• The importance of clinical trial phase 1
• Strategies to deal with the complexitieis of clinical trials landscape
• Interesting cases

Early clinical trials are one of the most exciting elements of the drug development life cycle. These trials can literally make or break the product that you have worked on for so many years. It is therefore of vital importance to understand what these trials are about and how they can be optimized to make the most out of this phase, that can be quite costly, especially if you are a small or mid-size biotech company. The webinar will provide you with these insights and to make this even more comprehensive, some good, bad and ugly examples (partly from in-house experience), will be presented.

Presenter:
Ronald van der Geest, Senior Consultant Clinical Development at 3D-PharmXchange

About the presenter:
​Ronald is one of the founders of 3D-PharmXchange. Next to his role as general partner, he holds roles as CDO at Treeway since 2013 and similar roles for a number of biotech companies. He is inventor on a substantial number of patents and an advisor for various strategic development programs in the life sciences and involved in the establishment of a number of early start-up companies.

More information and registration